ArticleOncogene2017
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.
M Apicella et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papertrialcites it